Searched for
PHARMA LOBBY GROUPS
Chinese business hired lobbying firm with ties to Donald Trump Jr, then scored a win in WashingtonA U.S. startup's bid to remove a Chinese investor from its board was rejected by a national security watchdog. A lobbying firm connected to...- Pharma companies struggle as input costs rise despite 0.6% price hikeFacing a modest 0.6% hike in medicine prices this year, pharmaceutical companies are grappling with the rising costs of raw materials fuele...
- Pharma lobby flags 'cumbersome' export rule, seeks changePharma lobby groups are urging for changes to the centralized no-objection certification (NOC) for drug exports due to a significant export...
- Pharma companies may lose licence if drugs fail testsThe health ministry is considering strict actions, including immediate license suspensions, for drugmakers producing substandard drugs. Thi...
- Indian Pharmaceutical Alliance calls for zero import duty on US drugs to boost local industryThe Indian Pharmaceutical Alliance (IPA) has proposed reducing the import duty on pharma products from the US to zero. Currently, India imp...
- Pharma companies may get time till December to comply with schedule M normsThe govt may extend the deadline for drug manufacturers to comply with revised Schedule M standards until December 2025. A final notificati...
- Pharma lobby, govt meet to discuss OTC drug regulationThe drug regulator had earlier this year formed an expert panel to evaluate medicines which can become OTC from prescription after pharmace...
- Lens on cos making drugs, supplements in same facility: Pharma body hopeful of a rethink on govt actionIn a recent diktat, the government said action will be taken against pharma units that are flouting the norms by manufacturing nutraceutica...
- Pharmaceutical bodies welcome uniform marketing code"We welcome the UCPMP. It is a balanced order that ensures that there is a healthy and ethical engagement between the pharmaceutical indust...
- India's pharma lobby bats for drug approvals in line with global marketsAccording to the OPPI, launching a new drug in India is delayed by up to four years, compared to markets like the US and the European Union...
- Pharma companies ask government to exempt cheap drugs from price controlThe pharmaceutical industry has sought an exemption from ceiling price for all low-priced formulations up to Rs 5 per unit. In a meeting he...
- Pharma sector marketing practices under government scannerA high-level committee formed under Niti Aayog's VK Paul held a meeting on Friday with the representatives of pharma lobby groups to review...
- Marketing practices framework: DoP panel to meet drug lobby groups"In the meeting as part of stakeholder consultations, the committee has desired to have the view of Organisation of Pharmaceutical Producer...
- Pharma lobby group backs granting of voluntary licenses by patent holders to Indian companies"Simple waiving of patents for vaccines is not enough for increased and free availability of Vaccines in India,” it said in a statement.The...
- Govt bulk drug scheme may allow exports, tooIndia is trying to encourage local manufacture of APIs, intermediates and key starting material used in the production of drugs and cut dep...
- Department of Pharmaceutical asks industry to regulate promotional practicesThe DoP secretary has told both the domestic and multinational pharma lobby groups along with the medical device industry to “strictly” com...
- India defends IP rights despite threats from US pharma lobby groupsThe annual report of Global Intellectual Property Centre, an organisation under the US Chamber of Commerce, has ranked India 43 among 45 co...
- Indian Drugs Manufacturing Association reviewing government directive on drug brandingIndian Drugs Manufacturing Association will take a call on legal action in its meeting on Friday after a new directive by the health minist...
- CCI cracks down on pharma companies for unfair trade practisesThe competition commission of India has cracked a whip on the Indian drug manufacturers for encouraging unfair trade practises by colluding...
- RIL, Nasscom, Sun Pharma & Orchid paid Rs 1.4 cr for lobbying in USReliance Industries, Nasscom, Sun Pharma and Orchid Chemicals -- have together paid close to $2,75,000 (about Rs 1.4 crore) towards lobbyin...
Load More
